Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,766 public trials 5,053 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

NCT07439653

Conditions
Hemic and Lymphatic Diseases, Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma, Immune System Diseases, +8 more
Locations
  • UCLA Santa Monica, California, United States
  • Stanford University Stanford, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Providence Medical Foundation Fullerton, California, United States
View Trial Details
Recruiting

A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)

NCT07116031

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • Children's Hospital Los Angeles- Site Number : 8400009 Los Angeles, California, United States
  • Children's National Medical Center - Washington- Site Number : 8400005 Washington D.C., District of Columbia, United States
  • Memorial Sloan Kettering Cancer Center - New York - York Avenue- Site Number : 8400001 New York, United States
  • Texas Children's Hospital- Site Number : 8400008 Houston, Texas, United States
View all 33 locations
View Trial Details
Recruiting

NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease

NCT07305818

Conditions
Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +7 more
Locations
  • Site # 1101 Hollywood, Florida, United States
  • Site # 1112 Miami, Florida, United States
  • Site # 1109 Wesley Chapel, Florida, United States
  • Site # 1107 Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Recruiting

A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant

NCT05623020

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Jupiter Medical Center/Anderson Family Cancer Institute Jupiter, Florida, United States
  • MSK Basking Ridge Basking Ridge, New Jersey, United States
  • MSK Monmouth Middletown, New Jersey, United States
  • MSK Bergen Montvale, New Jersey, United States
View all 139 locations
View Trial Details
Recruiting

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

NCT05765812

Conditions
Astrocytoma, Astrocytoma, Grade III, Glioblastoma, +17 more
Locations
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • New York University Langone Medical Center New York, United States
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York, United States
  • Baylor Scott & White Research Institute Dallas, Texas, United States
View all 16 locations
View Trial Details
Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

NCT06943872

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Uci Health Laguna Hills Laguna Hills, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Scripps Prebys Cancer Center San Diego, California, United States
View all 195 locations
View Trial Details
Recruiting

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

NCT07044297

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • University of Alabama at Birmingham-UAB 1917 Research Clinic ( Site 0006) Birmingham, Alabama, United States
  • USA Health University Hospitals ( Site 0020) Mobile, Alabama, United States
  • UCLA Center for Clinical AIDS Research and Education ( Site 0004) Los Angeles, California, United States
  • Bridge HIV - San Francisco Department of Public Health ( Site 0001) San Francisco, California, United States
View all 81 locations
View Trial Details
Recruiting

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

NCT03773965

Conditions
Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +7 more
Locations
  • Instituto CAICI SRL Rosario, Argentina
  • Centro de Investigaciones Médicas Tucuman SAN M. de Tucuman, Argentina
  • Royal Children's Hospital Melbourne, Australia
  • Perth Children's Hospital Perth, Australia
View all 78 locations
View Trial Details

Related conditions